1. Home
  2. SKYQ vs LYRA Comparison

SKYQ vs LYRA Comparison

Compare SKYQ & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYQ
  • LYRA
  • Stock Information
  • Founded
  • SKYQ 2019
  • LYRA 2005
  • Country
  • SKYQ United States
  • LYRA United States
  • Employees
  • SKYQ N/A
  • LYRA N/A
  • Industry
  • SKYQ
  • LYRA Medical/Dental Instruments
  • Sector
  • SKYQ
  • LYRA Health Care
  • Exchange
  • SKYQ NYSE
  • LYRA Nasdaq
  • Market Cap
  • SKYQ 13.5M
  • LYRA 11.8M
  • IPO Year
  • SKYQ N/A
  • LYRA 2020
  • Fundamental
  • Price
  • SKYQ $0.65
  • LYRA $0.11
  • Analyst Decision
  • SKYQ
  • LYRA Hold
  • Analyst Count
  • SKYQ 0
  • LYRA 4
  • Target Price
  • SKYQ N/A
  • LYRA $1.25
  • AVG Volume (30 Days)
  • SKYQ 43.0K
  • LYRA 950.4K
  • Earning Date
  • SKYQ 05-14-2025
  • LYRA 03-13-2025
  • Dividend Yield
  • SKYQ N/A
  • LYRA N/A
  • EPS Growth
  • SKYQ N/A
  • LYRA N/A
  • EPS
  • SKYQ N/A
  • LYRA N/A
  • Revenue
  • SKYQ $23,364,188.00
  • LYRA $1,534,000.00
  • Revenue This Year
  • SKYQ N/A
  • LYRA N/A
  • Revenue Next Year
  • SKYQ N/A
  • LYRA $519.89
  • P/E Ratio
  • SKYQ N/A
  • LYRA N/A
  • Revenue Growth
  • SKYQ N/A
  • LYRA N/A
  • 52 Week Low
  • SKYQ $0.56
  • LYRA $0.10
  • 52 Week High
  • SKYQ $5.49
  • LYRA $5.77
  • Technical
  • Relative Strength Index (RSI)
  • SKYQ N/A
  • LYRA 20.24
  • Support Level
  • SKYQ N/A
  • LYRA $0.14
  • Resistance Level
  • SKYQ N/A
  • LYRA $0.13
  • Average True Range (ATR)
  • SKYQ 0.00
  • LYRA 0.02
  • MACD
  • SKYQ 0.00
  • LYRA -0.01
  • Stochastic Oscillator
  • SKYQ 0.00
  • LYRA 11.10

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: